Ovia Pharma Private Limited
About Ovia Pharma Private Limited
Data last updated:
Ovia Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 September 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2010PTC208952. Its GSTIN is 22AABCO3762F1ZS (Chhattisgarh).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Poonam Agrawal and Pulkit Modi.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 55 2nd Floor Lane – 2 Westend Marg Saidullajab Near Saket Metro Station, New Delhi, Delhi, India – 110030.
As per the financials filed for FY 2022, the company reported a revenue of ₹37.48 Lakh, a growth of 41% compared to the previous year. For the same year it recorded a net loss of ₹20.1 Lakh (net margin -53.6%) and EBITDA of -₹20.04 Lakh (EBITDA margin -53.5%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 5% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ovia Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address55 2nd Floor Lane – 2 Westend Marg Saidullajab Near Saket Metro Station, New Delhi, Delhi, India – 110030
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ovia Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ovia Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ovia Pharma Private Limited, buy the company report.
Financials of Ovia Pharma Private Limited
FY 2022 filings availableOvia Pharma Private Limited reported revenue of ₹37.48 Lakh (up 41% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 41% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹20.04 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹20.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -53.5% | ||||
| Net Profit Margin | -53.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ovia Pharma Private Limited, buy the company report.
Board of directors of Ovia Pharma Private Limited
Ovia Pharma has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poonam Agrawal Also directs: Ovia Pharma Life Private Limited | Director | 25 May 2016 | 10 Years 4 Months | Current |
| Pulkit Modi Also directs: Pulkit Food and Packaging Private Limited | Director | 22 Nov 2017 | 8 Years 11 Months | Current |
| Nandita Bajpai | Director | 26 Oct 2012 | 13 Years 11 Months | Current |
| Ashish Krishan Bajpai | Director | 05 Feb 2011 | 15 Years 8 Months | Current |
| Naveen Agrawal Also directs: Ovia Pharma Life Private Limited | Director | 15 Apr 2016 | 10 Years 6 Months | Current |
Peer comparison
Ovia Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Crest Pharma Private Limited | ₹37.53 Lakh (FY 2023) | -13.0% | Patna, Bihar, India | |||
| Alletia Remedies Private Limited | ₹37.48 Lakh (FY 2024) | -19.0% | Delhi, India | |||
| Pragyan Pharmaceuticals Private Limited | ₹37.48 Lakh (FY 2021) | -28.0% | Kolar, Karnataka, India | |||
| Ovia Pharma Private Limitedthis company | ₹37.48 Lakh (FY 2022) | -₹20.1 Lakh | -53.6% | 41.0% | New Delhi, Delhi, India | |
| Aenor Pharmaceuticals Private Limited | ₹37.39 Lakh (FY 2024) | 15.0% | Ambala, Haryana, India |
To see the full peer comparison of Ovia Pharma Private Limited, buy the company report.
Auditor
Ovia Pharma Private Limited is audited by SAMEER SINGH & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SAMEER SINGH & ASSOCIATES | FY 2020 | 008664C |
Shareholding
The shareholding of Ovia Pharma Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Ovia Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ovia Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ovia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ovia Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22AABCO3762F1ZS | Chhattisgarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ovia Pharma Private Limited, buy the company report.
Recent activity
Ovia Pharma Private Limited has 9 board changes on record since 2011: 5 appointments and 4 cessations. The latest: Pulkit Modi was appointed as Director on 22 Nov 2017.
Frequently asked questions
Ovia Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 September 2010 (16+ years old) and is registered under CIN U51909DL2010PTC208952.
Ovia Pharma has 5 current directors:
- Poonam Agrawal - Director
- Pulkit Modi - Director
- Nandita Bajpai - Director
- Ashish Krishan Bajpai - Director
- Naveen Agrawal - Director
The latest financial statements of Ovia Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Ovia Pharma is 22AABCO3762F1ZS, registered in Chhattisgarh.
The CIN (Corporate Identification Number) of Ovia Pharma is U51909DL2010PTC208952. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ovia Pharma was incorporated on 30 September 2010, making it 16+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ovia Pharma by revenue are Crest Pharma Private Limited, Alletia Remedies Private Limited, Pragyan Pharmaceuticals Private Limited, Aenor Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Pulkit Modi was appointed as Director on 22 Nov 2017. Poonam Agrawal was appointed as Director on 25 May 2016. Poonam Agrawal ceased to be Additional Director on 25 May 2016. Ovia Pharma has 9 board changes on record in total.
The registered office of Ovia Pharma is at 55 2nd Floor Lane – 2 Westend Marg Saidullajab Near Saket Metro Station, New Delhi, Delhi, India – 110030.
Ovia Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Ovia Pharma is compliant as of 11 July 2026. The company is actively filing with the Registrar of Companies.